Source:http://linkedlifedata.com/resource/pubmed/id/19474717
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-8-4
|
pubmed:abstractText |
The medical management of short bowel syndrome frequently requires lifelong parenteral nutrition. Methods of increasing intestinal absorption and reducing parenteral nutrition dependence, by improving postresection intestinal adaptation, are increasingly being explored. Glucagon-like peptide-2 (GLP-2) is an important intestinotrophic growth factor and mediator of intestinal adaptation. This review summarizes our current understanding of GLP-2 physiology and provides an update on clinical trials in short bowel syndrome and related conditions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1535-3885
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
526-32
|
pubmed:meshHeading |
pubmed-meshheading:19474717-Adaptation, Physiological,
pubmed-meshheading:19474717-Glucagon-Like Peptide 2,
pubmed-meshheading:19474717-Humans,
pubmed-meshheading:19474717-Intestinal Absorption,
pubmed-meshheading:19474717-Intestinal Mucosa,
pubmed-meshheading:19474717-Nutritional Requirements,
pubmed-meshheading:19474717-Parenteral Nutrition,
pubmed-meshheading:19474717-Peptides,
pubmed-meshheading:19474717-Short Bowel Syndrome,
pubmed-meshheading:19474717-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Short bowel syndrome: the role of GLP-2 on improving outcome.
|
pubmed:affiliation |
Division of Medicine, Imperial College Healthcare, Hammersmith Hospital, London, UK. katharina.wallis@imperial.ac.uk
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|